Florian Denis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis...

The biotech startup's $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.

While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis...

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners

Investegate announcements from Mablink Bioscience, Mablink Bioscience announces a 31 million Series A